Purpose: We investigated the role of constitutive and inducible nitric oxide (NO) synthases in intestinal ischemia-reperfusion (I/R) injury by observing the alterations in hemodynamics and intestinal microcirculation in response to I/R in rats, with or without inhibitors of NO synthases. Methods: Adult male Sprague-Dawley rats (n = 9/group) received a standard T/R procedure alone: I/R plus intravenous administration of aminoguanidine tan inhibitor of inducible NO synthase I/R plus L-NAME (N(G)nitro-L-arginine methyl ester, an inhibitor of constitutive and inducible NO synthase); IR + L-Arg (L-arginine, an NO precursor); or a sham operation plus the vehicle. The I/R procedure was performed by clamping the perfusion vessels of a segment of the terminal ileum, and medication was administered intravenously before and after intestinal ischemia. The intestinal perfusion and leukocyte-endothelial interactions were evaluated with. in vivo microscopy and laser Doppler flowmetry. Surface expression of CD11b (an adhesion molecule) of circulating granulocytes was measured with flow cytometry. Results: Intestinal I/R produced circulatory alterations, intestinal microcirculatory derangement, energy depletion, and lipid peroxidation. Aminoguanidine significantly attenuated the reperfusion-related depression of mean arterial pressure (MAP), the decrease in intestinal perfusion index, the decrease in tissue ATP preservation, the increase in tissue malondialdehyde (MDA) level, and the expression of CD11b of circulating granulocytes. Administration of L-NAR IE had only minor and transient effects on reperfusion-related changes of MAP, intestinal flux, numbers of adherent leukocytes, and CD11b expression, but had some protective effects on tissue MDA and adenosine triphosphate levels and flow velocity. L-Arg further decreased the MAP but did not affect reperfusion-related variables. Conclusions: Our results show that the selective inhibition of inducible NO synthase by, aminoguanidine attenuates the hemodynamic and microcirculatory derangement that results from intestinal T/R.
机构:
Division of Cardiology, Department of Medicine, University of Alberta, EdmontonDivision of Cardiology, Department of Medicine, University of Alberta, Edmonton
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
Sato, Yuki
Itagaki, Shirou
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
Itagaki, Shirou
Oikawa, Setsu
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
Oikawa, Setsu
Ogura, Jiro
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
Ogura, Jiro
Kobayashi, Masaki
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
Kobayashi, Masaki
Hirano, Takeshi
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
Hirano, Takeshi
论文数: 引用数:
h-index:
机构:
Sugawara, Mitsuru
Iseki, Ken
论文数: 0引用数: 0
h-index: 0
机构:
Hokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, JapanHokkaido Univ, Div Pharmasci, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan
机构:Lawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Katada, Kazuhiro
Bihari, Aurelia
论文数: 0引用数: 0
h-index: 0
机构:Lawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Bihari, Aurelia
Badhwar, Amit
论文数: 0引用数: 0
h-index: 0
机构:Lawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Badhwar, Amit
Yoshida, Norimasa
论文数: 0引用数: 0
h-index: 0
机构:
Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, JapanLawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Yoshida, Norimasa
Yoshikawa, Toshikazu
论文数: 0引用数: 0
h-index: 0
机构:
Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Gastroenterol & Hepatol, Kyoto, JapanLawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Yoshikawa, Toshikazu
Potter, Richard F.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Western Ontario, Dept Surg, London, ON N6A 3K7, CanadaLawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Potter, Richard F.
Cepinskas, Gediminas
论文数: 0引用数: 0
h-index: 0
机构:
Lawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, CanadaLawson Hlth Res Inst, Ctr Crit Illness Res, Victoria Res Labs, London, ON N6A 4G5, Canada
Cepinskas, Gediminas
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
2009,
329
(03):
: 919
-
927